FIELD: medicine.
SUBSTANCE: on should apply the suggested compound of formula 1 
for treating and/or preventing osteoporosis and related osseous diseases.
EFFECT: higher efficiency of therapy and prophylaxis.
7 cl, 2 dwg, 21 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANALOGUES OF VITAMIN D, COMPOSITIONS CONTAINING INDICATED ANALOGUES AND THEIR USING | 2003 |
|
RU2320644C2 |
| ANALOGS OF VITAMIN D, PHARMACEUTICAL COMPOSITION, COMPOUNDS | 2000 |
|
RU2223953C2 |
| NEW ANALOGUES OF VITAMIN D | 2001 |
|
RU2261244C2 |
| COMPOUNDS, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2228928C2 |
| DERIVATIVES OF VITAMIN D, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2175318C2 |
| STEREOSELECTIVE SYNTHESIS OF VITAMINE D ANALOGUES | 2005 |
|
RU2380359C2 |
| DERIVATIVES OF VITAMIN D, COMPOUNDS PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, TREATMENT METHOD | 2001 |
|
RU2230738C9 |
| VITAMIN D ANALOGS, METHOD FOR THEIR OBTAINING, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2183622C2 |
| VITAMIN D ANALOG | 1991 |
|
RU2037484C1 |
| ANALOGS OF VITAMIN D, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUND, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2196132C2 |
